Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States ; volume:10 ; number:4 ; day:3 ; month:9 ; year:2021 ; pages:975-987 ; date:12.2021
Ophthalmology and therapy ; 10, Heft 4 (3.9.2021), 975-987, 12.2021
- Creator
-
Cockerham, Kimberly P.
Padnick-Silver, Lissa
Stuertz, Noel
Francis-Sedlak, Megan
Holt, Robert J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-021-00385-8
- URN
-
urn:nbn:de:101:1-2022012321031760397510
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cockerham, Kimberly P.
- Padnick-Silver, Lissa
- Stuertz, Noel
- Francis-Sedlak, Megan
- Holt, Robert J.
- SpringerLink (Online service)
Other Objects (12)
Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
Teprotumumab for the treatment of chronic thyroid eye disease
Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
Asymmetric proptosis in thyroid eye disease
Subclinical thyroid disorders and cognitive performance among adolescents in the United States
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
Teprotumumab for the treatment of chronic thyroid eye disease
Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
Asymmetric proptosis in thyroid eye disease
Subclinical thyroid disorders and cognitive performance among adolescents in the United States
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
Teprotumumab for the treatment of chronic thyroid eye disease
Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
Asymmetric proptosis in thyroid eye disease
Subclinical thyroid disorders and cognitive performance among adolescents in the United States
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY
United States (1952), United States Lines NY